article thumbnail

Teknova unveils new manufacturing facility for high-quality reagents

BioPharma Reporter

Teknova, a producer of life science reagents, has opened a new GMP-certified production facility which it claims will enable bioprocessing and gene therapy companies to get into the clinic faster.

Reagent 92
article thumbnail

Polyplus launches transfection reagent for large scale viral vector production

BioPharma Reporter

Recombinant adeno-associated viruses (rAAVs) are becoming the vector of choice for delivering gene therapies, says the French firm.

Reagent 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck builds in cell, gene therapies with Mirus Bio deal

pharmaphorum

Merck KGaA has agreed to a $600m deal to buy Mirus Bio, a specialist in transfection reagents used in the production of cell and gene therapies.

article thumbnail

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

When you consider the existing challenges limiting the upstream production of viral vectors, this figure becomes even more alarming. Better transfection reagents and efforts to automate the currently highly manual and inconsistent process could also make a difference, he adds.

Genomics 244
article thumbnail

Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot – ResearchAndMarkets.com

BioTech 365

Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot – ResearchAndMarkets.com Global Research Antibodies and Reagents Market Forecasts, 2020-2027: Focus on Antibodies, Production, Source, Research Area, Reagents, ELISA, Western Blot … Continue (..)

Reagent 40
article thumbnail

Sartorius upscales gene therapy prowess with $2.6bn Polyplus acquisition

Pharmaceutical Technology

The deal will see Polyplus join the German life science group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. Polyplus, based in Strasbourg, France, produces key components in the production of viral vectors used in cell and gene therapies.

article thumbnail

BioTek MicroFlo Select Microplate Reagent Dispenser

BioTech 365

C $51.51 (0 Bids)End Date: Monday Aug-24-2020 18:30:22 EDTBid now | Add to watch list Biotech365 : BioTek MicroFlo Select Microplate Reagent Dispenser BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic … Continue reading →

Reagent 45